The major goal of this overall Program Project is to dissect the role of the steroid receptor coactivator (SRC) family in mediating the tissue- selective biological functions of different steroid hormones and their cognate nuclear receptors. (NRs). Our working hypothesis in this Project is that the specificity of coactivator requirement for NRs in target tissues is a function of (i) the intracellular concentrations of coactivators and liganded NRs and (ii) the inherent affinities between specific liganded NR-coactivator pairs. These tissues will be integrated in three Specific Aims.
In Specific Aims 1 and 2, we will set out to determine, using multiple tissues and under conditions of ligand induction or withdrawal and in models of the disease states in which NR signaling pathways are implicated, such as type II diabetes, such as type II diabetes, obesity, hyperlipidemia.
In Specific Aim 3, we will generate data on the patterns of coactivator selectivity by different NRs by sensitive measurement of the inherent affinities of individual receptor-coactivator pairs using purified receptors. The results we envisage are essential for our understanding of the tissue-specific biology of members of the SRC family. In addition, these studies will pave the way for a greater understanding of the mode of action of selective receptor modulators (SRMs), and will provide prospects for their therapeutic application in the myriad endocrine and metabolic disorders in which NRs and, by association SRCs, are implicated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK059820-02
Application #
6618183
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-08-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
Rohira, Aarti D; Yan, Fei; Wang, Lei et al. (2017) Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells. Cancer Res 77:4293-4304
Zhao, Fei; Franco, Heather L; Rodriguez, Karina F et al. (2017) Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice. Science 357:717-720
Xu, Yong; O'Malley, Bert W; Elmquist, Joel K (2017) Brain nuclear receptors and body weight regulation. J Clin Invest 127:1172-1180
Xu, Y; Qin, L; Sun, T et al. (2017) Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression. Oncogene 36:1157-1166
Xie, Xin; Wu, San-Pin; Tsai, Ming-Jer et al. (2017) The Role of COUP-TFII in Striated Muscle Development and Disease. Curr Top Dev Biol 125:375-403
Yi, Ping; Wang, Zhao; Feng, Qin et al. (2017) Structural and Functional Impacts of ER Coactivator Sequential Recruitment. Mol Cell 67:733-743.e4
Lee, Hui-Ju; Kao, Chung-Yang; Lin, Shih-Chieh et al. (2017) Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. Sci Rep 7:3136
Wang, Leiming; Xu, Mafei; Qin, Jun et al. (2016) MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer. Oncotarget 7:14673-83
Xie, Xin; Tsai, Sophia Y; Tsai, Ming-Jer (2016) COUP-TFII regulates satellite cell function and muscular dystrophy. J Clin Invest 126:3929-3941

Showing the most recent 10 out of 181 publications